BRWA
ACIU icon

B. Riley Wealth Advisors’s AC Immune ACIU Stock Holding History

B. Riley Wealth Advisors’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,500
Closed -$84K – 1407
2021
Q2 		$84K Buy
+10,500
New +$72.6K ﹤0.01% 1325

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

B. Riley Wealth Advisors's ACIU Position: Q3 2021 in Review

B. Riley Wealth Advisors sold out of AC Immune (ACIU) in Q3 2021, closing a stake of 10,500 shares — an estimated $84K sold.

B. Riley Wealth Advisors first reported a position in ACIU in Q2 2021 and held it in 1 quarter. The position peaked at $84K in Q2 2021. 64 funds tracked by Wall St. Rank hold ACIU as of Q3 2021.

  • B. Riley Wealth Advisors reported no remaining AC Immune position as of Q3 2021 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 10,500 AC Immune shares in Q3 2021, an estimated $84K.
  • B. Riley Wealth Advisors first reported a position in AC Immune in Q2 2021 and held it in 1 quarter.
  • B. Riley Wealth Advisors's AC Immune position peaked at $84K in Q2 2021.
  • 64 funds tracked by Wall St. Rank held AC Immune as of Q3 2021.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.